Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Journal of Medicinal Chemistry
|
January 10, 2025
Discovery of Novel Small-Molecule Inhibitors Disrupting the MTDH-SND1 Protein-Protein Interaction
Hao Shen, Jiayu Ding, Jiaying Ji, et al.
Physical Review Letters
|
October 31, 2025
Suppressing Spurious Transitions Using Spectrally Balanced Pulse
Ruixia Wang, Yaqing Feng, Yujia Zhang, et al.
Angewandte Chemie (International Ed. in English)
|
May 28, 2026
Light-Activated Isolation of High-Quality Mitochondria for Therapeutic Transplantation
Hui Liu, Yuxin Jiao, Ting Zhang, et al.
Journal of Medicinal Chemistry
|
July 9, 2025
Design, Synthesis, and Activity Evaluation of Novel Nucleosides as ADAR1 Inhibitor for the Treatment of Prostate Cancer
Yasheng Zhu, Hao Shen, Jiayu Ding, et al.
Journal of Medicinal Chemistry
|
April 14, 2025
Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer
Jiaxing Li, Chengliang Sun, Ying Zhang, et al.
Journal of Medicinal Chemistry
|
June 3, 2025
Discovery of a Novel and Potent <i>MET</i> Transcription Inhibitor Targeting Promoter G-Quadruplex for the Treatment of NSCLC
Wenjian Min, Chunling Chen, Zhongrui Shi, et al.
Journal of Medicinal Chemistry
|
March 9, 2026
Rational Design of Potent and Orally Efficacious PI3Kα/δ Degrader for PIK3CA Mutant Breast Cancer without Hyperglycemic Liability
Yi Hou, Xinqing Zheng, Yiwen Zhang, et al.
Leukemia
|
December 20, 2024
ADAR1 is required for acute myeloid leukemia cell survival by modulating post-transcriptional Wnt signaling through impairing miRNA biogenesis
Zhongrui Shi, Jiaxing Li, Jiayu Ding, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 20, 2025
ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD-Mediated EMT Signaling Pathway
Jiayu Ding, Hao Shen, Jiaying Ji, et al.
Nature Communications
|
May 25, 2022
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer
Kai Yuan, Zhaoxing Li, Wenbin Kuang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Journal of Medicinal Chemistry
|
January 10, 2025
Discovery of Novel Small-Molecule Inhibitors Disrupting the MTDH-SND1 Protein-Protein Interaction
Hao Shen, Jiayu Ding, Jiaying Ji, et al.
Physical Review Letters
|
October 31, 2025
Suppressing Spurious Transitions Using Spectrally Balanced Pulse
Ruixia Wang, Yaqing Feng, Yujia Zhang, et al.
Angewandte Chemie (International Ed. in English)
|
May 28, 2026
Light-Activated Isolation of High-Quality Mitochondria for Therapeutic Transplantation
Hui Liu, Yuxin Jiao, Ting Zhang, et al.
Journal of Medicinal Chemistry
|
July 9, 2025
Design, Synthesis, and Activity Evaluation of Novel Nucleosides as ADAR1 Inhibitor for the Treatment of Prostate Cancer
Yasheng Zhu, Hao Shen, Jiayu Ding, et al.
Journal of Medicinal Chemistry
|
April 14, 2025
Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer
Jiaxing Li, Chengliang Sun, Ying Zhang, et al.
Journal of Medicinal Chemistry
|
June 3, 2025
Discovery of a Novel and Potent <i>MET</i> Transcription Inhibitor Targeting Promoter G-Quadruplex for the Treatment of NSCLC
Wenjian Min, Chunling Chen, Zhongrui Shi, et al.
Journal of Medicinal Chemistry
|
March 9, 2026
Rational Design of Potent and Orally Efficacious PI3Kα/δ Degrader for PIK3CA Mutant Breast Cancer without Hyperglycemic Liability
Yi Hou, Xinqing Zheng, Yiwen Zhang, et al.
Leukemia
|
December 20, 2024
ADAR1 is required for acute myeloid leukemia cell survival by modulating post-transcriptional Wnt signaling through impairing miRNA biogenesis
Zhongrui Shi, Jiaxing Li, Jiayu Ding, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 20, 2025
ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD-Mediated EMT Signaling Pathway
Jiayu Ding, Hao Shen, Jiaying Ji, et al.
Nature Communications
|
May 25, 2022
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer
Kai Yuan, Zhaoxing Li, Wenbin Kuang, et al.
Page
of 5